ANI Pharmaceuticals, Inc. (ANIP) NASDAQ

79.61

-1.2654(-1.56%)

Updated at May 14 11:25AM

Currency In USD

ANI Pharmaceuticals, Inc.

Address

210 Main Street West

Baudette, MN 56623

United States of America (the)

Phone

218 634 3500

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

897

First IPO Date

May 05, 2000

Key Executives

NameTitlePayYear Born
Nikhil LalwaniPresident, Chief Executive Officer & Director2.43M1978
Chad GassertSenior Vice President of Corporate Development & Strategy849,7111976
Meredith W. CookSenior Vice President, General Counsel & Corporate Secretary860,8081974
Ori GutwergSenior Vice President of Generics964,1481975
Stephen CareySenior Vice President of Finance & Chief Financial Officer1.12M1971
Christopher K. MutzSenior Vice President & Head of Rare Disease1.27M1972
Mary PaoChief Medical Officer0N/A
Muthusamy ShanmugamHead of R&D, Chief Operating Officer of New Jersey Operations & Director01968
Thomas Andrew RowlandSenior Vice President & Head of Established Brands01967
Elizabeth PowellChief Compliance Officer & Head of Legal of Rare Disease0N/A
Krista L. DavisSenior Vice President & Chief Human Resources Officer01973

Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.